Immediate Impact
32 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Uri Abadi being referenced
Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
2020
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T‐cell lymphoma: Real‐life data from a national multicenter observational study
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Uri Abadi | 127 | 119 | 46 | 67 | 28 | 279 | |
| Anna Johnston | 108 | 123 | 48 | 71 | 37 | 325 | |
| Leyre Bento | 76 | 86 | 22 | 88 | 31 | 229 | |
| Wanda Knopińska‐Posłuszny | 108 | 119 | 39 | 104 | 37 | 321 | |
| Maria Chiara Tisi | 135 | 148 | 21 | 34 | 25 | 283 | |
| Pierre Feugier | 81 | 91 | 39 | 79 | 21 | 278 | |
| Praveen Ramakrishnan Geethakumari | 170 | 74 | 18 | 41 | 45 | 283 | |
| Sandra P. Susanibar-Adaniya | 161 | 126 | 30 | 49 | 27 | 301 | |
| Sung-Nam Lim | 78 | 76 | 40 | 97 | 34 | 252 | |
| Colin Phipps Diong | 89 | 47 | 38 | 43 | 23 | 264 | |
| Jean‐Pierre Vilque | 126 | 71 | 39 | 77 | 18 | 250 |
All Works
Login with ORCID to disown or claim papers
Loading papers...